ISSUE: 1998/06/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers

References: Basic Science / Neuroblastoma Research

References: Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Next Issue of Recent Publications (1998/07/a)

Back to NBL-PROF Home Page

Clinical / Prognostic Markers

Cheung NKV, et al. 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study. Int J Oncol. 1998 Jun; 12(6): 1299-1306.    [Related articles]     Trials & Studies

Goldberg SS, et al. Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma. Med Pediatr Oncol. 1998 Jun; 30(6): 339-346.    [Related articles]

Katzenstein HM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the Pediatric Oncology Group experience. J Clin Oncol. 1998 Jun; 16(6): 2007-2017.    [Related articles]     MYCN Amplification

Matthay KK. Stage 4S neuroblastoma: what makes it special ? J Clin Oncol. 1998 Jun; 16(6): 2003-2006    [Related articles]

Yu AL, et al. Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol. 1998 Jun; 16(6): 2169-2180.    [Related articles]     Trials & Studies

Basic Science / Neuroblastoma Research

Easton J, et al. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Cancer Res. 1998; Jun 15; 58: 2624-2632.    [Related articles]

Fishwick J, et al. Binding of dihydroartemisinin to differentiating neuroblastoma cells and rat cortical homogenate. Neurotoxicology. 1998 Jun; 19(3): 405-412.    [Related articles]

Fishwick J, et al. Morphological and immunocytochemical effects of dihydroartemisinin on differentiating NB2a neuroblastoma cells. Neurotoxicology. 1998 Jun; 19(3): 393-403.    [Related articles]

Latasa MJ, et al. Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells. Endocrinology. 1998 Jun; 139(6): 2692-2698.    [Related articles]

Mannello F, et al. Prostate-specific antigen expression in neuroblastoma cell lines. [letter] Clin Chem. 1998 Jun; 44(6 Pt 1): 1362-1363.    [Related articles]

Maruyama W, et al. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide. J Neurochem. 1998 Jun; 70(6): 2510-2515.    [Related articles]

Morash SC, et al. Overexpression of myristoylated alanine-rich C-kinase substrate enhances activation of phospholipase D by protein kinase C in SK-N-MC human neuroblastoma cells. Biochem J. 1998 Jun 1; 332( Pt 2): 321-327    [Related articles]

Wang W, et al. Effects of a peptide analogue of the amphiphilic domain of the common neurotrophin receptor on nerve growth factor-mediated motility of human neuroblastoma cells. J Neurochem. 1998 Jun; 70(6): 2327-2335.    [Related articles]

Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Yamauchi T, et al. Neurite outgrowth of neuroblastoma cells overexpressing alpha and beta isoforms of Ca2+/calmodulin-dependent protein kinase II-effects of protein kinase inhibitors. Brain Res Brain Res Protoc. 1998 Jun 1; 2(4): 250-258.    [Related articles]

Next Issue of Recent Publications (1998/07/a)
Back to NBL-PROF Home Page